IlluminOss Medical Names Dirk Kuyper as Chief Executive Officer

EAST PROVIDENCE, RI–(Marketwired – Apr 9, 2013) – IlluminOss Medical, a privately held clinical stage medical device company pioneering the development of minimally invasive, patient-customized orthopedic systems for the stabilization and treatment of bone fractures, today announced that Dirk M. Kuyper has joined the company as president and CEO. Mr. Kuyper has had a long and successful career in medical device companies, with his efforts focused on development and implementation of strategy, and driving revenue growth from key market segments. The company has received the CE Mark for clinical applications in the upper extremities, and is extending the platform technology to lower extremity bones and indications in cranio-maxillofacial, spine, and sports medicine fields.
Mr. Kuyper comes to IlluminOss from publicly traded Alphatec Spine where he was president & CEO. He spent 17 years at Aesculap, Inc., a subsidiary of B. Braun Medical Inc., where he rose from a regional sales manager to serve eventually as president. Prior to that, he had extensive experience in sales and marketing at several medical device companies. He received his Bachelor of Science degree in Biology from the University of Miami and an Executive Education Certificate from the Graduate School of Sales and Marketing at Syracuse University. He achieved the rank of captain in the United States Army.
“Dirk Kuyper is the ideal person to move the company into the commercialization phase of our life cycle,” said Robert Rabiner, founder and chief technology officer of IlluminOss. “I look forward to working closely with him to implement market acceptance and distribution of our innovative products while I focus on further development of our technology.”
“The technology Bob Rabiner and his team have developed has the potential to change the standard of care in fracture management,” said Mr. Kuyper. “I am excited about being part of the team and leveraging my global commercialization background to help build IlluminOss into a leading company in the fracture fixation marketplace.”The IlluminOss Photodynamic Bone Stabilization System creates internal bone support and alignment systems utilizing expandable balloon catheters and a photodynamic (light-curable) polymer system designed to provide stabilization, cosmesis, and flexible surgical approaches in orthopedics.The global bone fracture repair market was an estimated $5.5 billion in sales in 2010 and growing approximately 6% per annum, driven by population growth and aging populations around the globe.
About IlluminOss Medical
IlluminOss Medical is a privately held clinical stage medical device company pioneering the development of minimally invasive, patient customized orthopedic systems for the stabilization and treatment of bone fractures. The IlluminOss Photodynamic Bone Stabilization System creates internal bone support and alignment systems utilizing expandable balloon catheters and a photodynamic (light-curable) polymer system designed to provide stabilization, cosmesis, and flexible surgical approaches in orthopedics. The company has received the CE Mark for clinical applications in the upper extremities, and is extending the platform technology to lower extremity bones and indications in cranio-maxillofacial, spine, and sports medicine fields. Founded in 2007, IlluminOss is headquartered in East Providence, RI, and funded by Foundation Medical Partners, New Leaf Venture Partners, Tekla Capital, Life Sciences Partners, Excel Venture Management, SR One, Longwood Fund, Pappas Ventures, Mieza Capital and Slater Technology Fund. Learn more at www.illuminoss.com.